Sarcopenia News
Rejuvenate Biomed's potential drug candidate combats sarcopenia in older adults
Rejuvenate Biomed - 21-Feb-2024
Phase 1b trial shows RJx-01's ability to improve muscle strength, function, and fatigue resistance
Read more...Phase 2 clinical trial of lead drug candidate MYMD-1- a therapy for delaying aging
Business Wire - 26-Jul-2022
Sarcopenia drug trial shows no evidence of toxicity or safety issues
Read more...Sarconeos BIO101 in development for the treatment of Sarcopenia by Biophytis
Yahoo! finance - 27-Jun-2022
SARA-INT Phase 2 study and SARA Phase 3 study milestones in developing sarconeos
Read more...MyMD Pharmaceuticals begins phase 2 trial of TNF-inhibitor in January 2022
Longevity Technology - 14-Dec-2021
Potential oral treatment to prevent sarcopenia and frailty, and extend healthy lifespan
Read more...Role of Neuromuscular junction in ageing and neuro muscular diseases
Fight Aging! - 17-Aug-2021
Neuromuscular junction: A potential therapeutic target in neuromuscular injury
Read more...Klotho protein reversed muscle ageing in old, but not older mice
eLife Sciences - 20-Apr-2021
Potential future treatment strategy to prevent sarcopenia when supplemented at a young age
Read more...A man-made molecule that helps repair and regenerate muscle tissue
EurekAlert! - 23-Mar-2021
Givinostat induces stem cells to produce muscle making cells - promising therapy for age-related muscle loss
Read more...Rejuvenate Biomed raises 3.2 million euros for anti-ageing drugs
PharmiWeb.com - 02-Mar-2021
Accelerates clinical trial plans for its lead candidate Rlx-01 targeting age-related muscle failure
Read more...
